Prolyl hydroxylase inhibitors

Details for Australian Patent Application No. 2008329746 (hide)

Owner GlaxoSmithKline LLC

Inventors Fitch, Duke M.

Agent Davies Collison Cave

Pub. Number AU-A-2008329746

PCT Pub. Number WO2009/070644

Priority 60/991,283 30.11.07 US

Filing date 26 November 2008

Wipo publication date 4 June 2009

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/47 (2006.01) - Quinolines

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

17 June 2010 PCT application entered the National Phase

  PCT publication WO2009/070644 Priority application(s): WO2009/070644

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008329747-Indoles, derivatives, and analogs thereof and uses thereof

2008329741-Method of increasing immunological effect